Cramer's 'Mad Money' Recap: Maintaining Market Discipline (Final)

Search Jim Cramer's Mad Money trading recommendations using our exclusive Mad Money Stock Screener and watch Jim Cramer's Mad Money Post Game video exclusively on TheStreet.com.


NEW YORK ( TheStreet) -- "Don't lose your discipline," Jim Cramer warned his "Mad Money" TV show viewers after another modest gain on Tuesday on Wall Street.

Cramer told investors that even though the market may continue higher, they should take some profits and wait for a pullback before buying back in. He then explained what's going right for the markets, and what we still should be worried about.

On the plus side, Cramer said the Chinese stock market has bottomed, meaning that a recovery should be close at hand. Cramer said that's good news for materials stocks, especially copper plays like Freeport McMoRan ( FCX), but also other industrials like Honeywell ( HON) and Joy Global ( JOYG).

Another positives for the markets include auto sales, said Cramer, but that move is mainly benefiting the parts makers like Borg Warner ( BWA). There's also a bottom forming in housing, he said, and that matters big for job creation.

But on the negative side, worries in Europe still loom, with debts in Italy being of special concern. Cramer said that Juniper Networks ( JNPR) poured cold water on the tech rally today with a weak outlook and he's now concerned that semiconductors may not be as hot as once thought.

Cited cited the high price of oil amidst increased geo-political tensions as another worry for the markets, as are the bank stocks. "Don't overstay your welcome in the banks," he said, once again reiterating Wells Fargo ( WFC) and US Bancorp ( USB), a stock which he owns for his charitable trust, Action Alerts PLUS, among the only two investable banks out there.

"Ignoring the negatives proved costly last year," warned Cramer, as he told viewers not to forget the lessons of the past.

Delivering on All Fronts

In the "Executive Decision" segment, Cramer spoke with Dr. Leonard Schleifer, president and CEO of Regeneron Pharmaceuticals ( REGN), a biotech company that's seen a spectacular 1,400% gain since Cramer first featured the company on "Mad Money" in the spring of 2005.

Schleifer painted a bullish picture of Regeneron on the heels of successes with its drug Eylea, used in treating many blinding eye diseases. Schleifer said that from the beginning, Regeneron wanted to create a drug that doctors would love, that patients would love and that insurance companies would be happy to pay for. "We've delivered on all fronts," Schleifer declared.

Eylea's strength comes from the fact that the in-eye injection is only needed once every two month, as compared to monthly for its rival. Given how uncomfortable patients are with shots in the eye, Schleifer said it's easy to see why so many are opting for once every two months.

But Regeneron is much more than a one-hit wonder, said Cramer. Schleifer noted that the company is also working with Sanofi-Aventis ( SNY) on two promising projects, one for colo-rectal cancer and the other, a cholesterol lowering medication that "dramatically" lowers a patient's cholesterol levels.

Schleifer also comments on Regeneron's pricing model, which is notably lower than its rivals. "You can't just charge anything you want to charge anymore," said Schleifer, who has chosen instead to price Regeneron's drugs affordably for both patients and insurance payers.

Cramer said that Regeneron remains a great story with a lot of upside potential still to come. He reiterated his recommendation.

Housing Bottom Play

"The bottom in housing has arrived," Cramer told viewers, as he continued his series of indirect ways to play the looming recovery in domestic housing. The homebuilders are too risky, he said, but a company like Masco ( MAS), which makes building products like kitchen and bath cabinets and plumbing fixtures, is right in the sweet spot.

Shares of Masco are already up 65% since October, but Cramer said compared to five years ago, when shares traded near $35 a share, this is one stock that still has a lot of room to run.

He said unlike the home builders, which rely 100% on new home construction, Masco only derives one-third of its sales from new homes. The bulk of its sales, 46%, comes from home repair and remodeling, which is one of the first sectors to recover as consumers begin to feel confident about their homes again.

Cramer said the analysts covering Masco are simply clueless. He said while many have slashed their earnings estimates for the company, only one rates the company a buy, while 13 rate it a hold and two rate it a sell. The beginning of a recovery is not the time to hold or sell, said Cramer. The time to buy is before the bottom becomes obvious to everyone, he noted.

Off the Charts

Cramer went head to head with colleague Scott Redler over the charts of the homebuilder using the PHLX Housing Index ( HGX) as a proxy for the group that has been on fire since last October.

According to Redler, the daily chart of the index clearly shows the hard snap-back rally the homebuilders have been experiencing after years of declines. The series of higher lows indicates that buyers are buying aggressively on the weakness and Redler liked that the index was above all of its key moving averages.

That said, Redler noted that the index has moved too far, too fast and needs a pullback before he would be a buyer. If the index slipped below $97 a share however, that could signal that the recent rally is just another in a series of costly false-starts for the housing sector.

Turning to the weekly chart, Redler was also bullish, noting that the index is hitting a tough ceiling and will likely trade sideways or pull back a bit before advancing above $111 a share, a key level for the group. If it can take out the $111 level, Redler sees a rise of 18%.

Cramer said he agrees with Redler that housing is on the move, but the group is vulnerable up at these levels. He said a better play would be to avoid the homebuilders themselves and stick with the housing-related stocks he's been mentioning all week long.

Lightning Round

Cramer was bullish on Macy's ( M), Biogen Idec ( BIIB), Sanofi-Aventis ( SNY), Abbott Laboratories ( ABT), B&G Foods ( BGS), Cubist Pharmaceuticals ( CBST) and Herbalife ( HLF).

Cramer was bearish on Travelzoo ( TZOO), Teva Pharmaceutical ( TEVA) and Dole Food ( DOLE).

Closing Comments

In his "No Huddle Offense" segment, Cramer reminded viewers that at the right price, any stock can be attractive. Consider Alcoa ( AA) and Juniper Networks ( JNPR), an Action Alerts PLUS stock.

Cramer said that when Alcoa reported a miserable quarter, the stock actually rallied. Why? Because the bad news was already widely expected and was "baked into" the stock price. The same was true for Juniper, which pre-announced sluggish sales and saw its shares jump on the news instead of getting pummeled as one would expect.

Cramer said when everyone expects something to be happen, investors can be surprised by the reaction when the news actually occurs. It just goes to show that every stock has a price where buyers will eventually step in.

--Written by Scott Rutt in Washington, D.C.

To contact the writer of this article, click here: Scott Rutt.

Follow TheStreet on Twitter and become a fan on Facebook.

To submit a news tip, send an email to: tips@thestreet.com.

To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.

Want more Cramer? Check out Jim's rules and commandments for investing from his latest book by clicking here.

For more of Cramer's insights during the Lightning Round, clickhere .

At the time of publication, Cramer was long US Bancorp, Juniper Networks.

Jim Cramer, host of the CNBC television program "Mad Money," is a Markets Commentator for TheStreet.com, Inc., and CNBC, and a director and co-founder of TheStreet.com. All opinions expressed by Mr. Cramer on "Mad Money" are his own and do not reflect the opinions of TheStreet.com or its affiliates, or CNBC, NBC UNIVERSAL or their parent company or affiliates. Mr. Cramer's opinions are based upon information he considers to be reliable, but neither TheStreet.com, nor CNBC, nor either of their affiliates and/or subsidiaries warrant its completeness or accuracy, and it should not be relied upon as such. Mr. Cramer's statements are based on his opinions at the time statements are made, and are subject to change without notice. No part of Mr. Cramer's compensation from CNBC or TheStreet.com is related to the specific opinions expressed by him on "Mad Money."

None of the information contained in "Mad Money" constitutes a recommendation by Mr. Cramer, TheStreet.com or CNBC that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the program. Mr. Cramer's past results are not necessarily indicative of future performance. Neither Mr. Cramer, nor TheStreet.com, nor CNBC guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the program. The strategy or investments discussed may fluctuate in price or value and you may get back less than you invested. Before acting on any information contained in the program, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.

Some of the stocks mentioned by Mr. Cramer on "Mad Money" are held in Mr. Cramer's Action Alerts PLUS Portfolio. When that is the case, appropriate disclosure is made on the program and in the "Mad Money" recap available on TheStreet.com. The Action Alerts PLUS Portfolio contains all of Mr. Cramer's personal investments in publicly-traded equity securities only, and does not include any mutual fund holdings or other institutionally managed assets, private equity investments, or his holdings in TheStreet.com, Inc. Since March 2005, the Action Alerts PLUS Portfolio has been held by a Trust, the realized profits from which have been pledged to charity. Mr. Cramer retains full investment discretion with respect to all securities contained in the Trust. Mr. Cramer is subject to certain trading restrictions, and must hold all securities in the Action Alerts PLUS Portfolio for at least one month, and is not permitted to buy or sell any security he has spoken about on television or on his radio program for five days following the broadcast.

More from Jim Cramer

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

Using Technical Analysis to Profit: Cramer's 'Mad Money' Recap (Friday 5/18/18)

Using Technical Analysis to Profit: Cramer's 'Mad Money' Recap (Friday 5/18/18)

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing

Cramer Equates Investing to Blackjack -- and so the Market Becomes the House.

Cramer Equates Investing to Blackjack -- and so the Market Becomes the House.

Cramer's Team is Being Patient with the Financials -- Though They May Add More

Cramer's Team is Being Patient with the Financials -- Though They May Add More